Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

International Journal of Clinical Oncology

Volumn 14, Issue 5, 2009, Pages 436-441

  Shiraishi, Takumi ^a   Nakamura, Terukazu ^a   Mikami, Kazuya ^a   Takaha, Natsuki ^a   Kawauchi, Akihiro ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gemcitabine; Germ cell tumor; Nedaplatin; Paclitaxel; Salvage chemotherapy

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IRINOTECAN; NEDAPLATIN; PACLITAXEL; RANITIDINE;

ADULT; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYBERKNIFE; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FOLLOW UP; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER TOXICITY; LUNG METASTASIS; LYMPH NODE METASTASIS; MESENTERY PANNICULITIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PANNICULITIS; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; PSOAS ABSCESS; RADIOFREQUENCY ABLATION; SALVAGE THERAPY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CATHETER ABLATION; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350513915     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0899-y     Document Type: Article

References (23)

1. E.H. Einhorn 1997 Testicular cancer: an oncological success story Clin Cancer Res 3 2630 2632 1:STN:280:DyaK1M7mtlCjuw%3D%3D 10068265
2. F. Farhat S. Culine C. Theodore, et al. 1996 Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience Cancer 77 1193 1197 10.1002/(SICI)1097-0142(19960315)77:6<1193::AID- CNCR28>3.0.CO;2-W 1:CAS:528:DyaK28XitVGqtLw%3D 8635143 (Pubitemid 26080913)
3. J.A. McCaffrey M. Mazumdar D.F. Bajorin, et al. 1997 Ifosfamideand cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival J Clin Oncol 15 2559 2563 1:CAS:528: DyaK2sXkslymsrY%3D 9215825
4. P.J. Loehrer Sr R. Gonin C.R. Nichols, et al. 1998 Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor J Clin Oncol 16 2500 2504 1:CAS:528:DyaK1cXks1Gnur8%3D 9667270
5. J.L. Pico G. Rosti A. Kramar, et al. 2005 A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours Ann Oncol 16 1152 1159 10.1093/annonc/mdi228 15928070 (Pubitemid 41418319)
6. R.J. Motzer J. Sheinfeld M. Mazumdar, et al. 2000 Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer J Clin Oncol 18 2413 2418 1:CAS:528:DC%2BD3cXkvFWrsb8%3D 10856101 (Pubitemid 30415828)
7. G.V. Kondagunta J. Bacik A. Donadio, et al. 2005 Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors J Clin Oncol 23 6549 6555 10.1200/JCO.2005.19.638 1:CAS:528:DC%2BD2MXhtFWqsLnE 16170162 (Pubitemid 46190247)
8. Miki T, Mizutani Y, Nomoto T, et al. (2006) Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for cisplatin refractory germ cell tumors. Proc Am Soc Clin Oncol (abstract 4587)
9. N. Nonomura D. Oka K. Nishimura, et al. 2007 Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors Int J Urol 14 527 531 10.1111/j.1442-2042.2006.01702.x 1:CAS:528:DC%2BD2sXpt1emtb4%3D 17593098 (Pubitemid 46985529)
10. C. Bokemeyer A. Gerl P. Schoffski, et al. 1999 Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer J Clin Oncol 17 512 516 1:CAS:528:DyaK1MXht1Wmurs%3D 10080593 (Pubitemid 29075236)
11. L.H. Einhorn M.J. Stender S.D. Williams 1999 Phase II trial of gemcitabine in refractory germ cell tumors J Clin Oncol 17 509 511 1:CAS:528:DyaK1MXht1Wmuro%3D 10080592
12. R.J. Motzer D.F. Bajorin L.H. Schwartz, et al. 1994 Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors J Clin Oncol 12 2277 2283 1:STN:280:DyaK2M%2FlsVantQ%3D%3D 7525885
13. C. Bokemeyer J. Beyer B. Metzner, et al. 1996 Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer Ann Oncol 7 31 34 1:STN:280:DyaK2s%2Fns12qtw%3D%3D 9081388
14. C. Kollmannsberger O. Rick H.G. Derigs, et al. 2002 Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group J Clin Oncol 20 2031 2037 10.1200/JCO.2002.08.050 1:CAS:528:DC%2BD38XjvVKmsro%3D 11956262 (Pubitemid 34408792)
15. C. Kollmannsberger O. Rick H. Klaproth, et al. 2002 Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group Br J Cancer 87 729 732 10.1038/sj.bjc.66000524 1:CAS:528:DC%2BD38XmvF2ksrY%3D 12232755 (Pubitemid 35178750)
16. S. Hinton P. Catalano L.H. Einhorn, et al. 2002 Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group J Clin Oncol 20 1859 1863 10.1200/JCO.2002.07.158 1:CAS:528:DC%2BD38XjtFGqsrk%3D 11919245 (Pubitemid 34273277)
17. L.H. Einhorn M.J. Brames B. Juliar, et al. 2007 Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant J Clin Oncol 25 513 516 10.1200/JCO.2006.07.7271 1:CAS:528:DC%2BD2sXivF2mtL8%3D 17290059 (Pubitemid 350002957)
18. Pizzocaro G, Nicolai N, Salvioni R (2001) Paclitaxel, cisplatin and gemcitabine (TGP) third line therapy in metastatic germ cell tumors (GCT) of the testis. Proc Am Soc Clin Oncol (abstract 773)
19. J. Mardiak T. Salek Z. Sycova-Mila, et al. 2005 Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study Neoplasma 52 243 247 15875087 (Pubitemid 40776437)
20. H. Akaza M. Togashi Y. Nishio, et al. 1992 Phase II study of cisdiammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group Cancer Chemother Pharmacol 31 187 192 10.1007/BF00685546 1:STN:280:DyaK3s%2FpvFKksg%3D%3D 1334448
21. M. Fukuda T. Shinkai K. Eguchi, et al. 1990 Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer Cancer Chemother Pharmacol 26 393 396 10.1007/BF02994087 1:STN:280:DyaK3M%2FivFyjuw%3D%3D 2171794
22. T. Miki Y. Mizutani N. Nonomura, et al. 2002 Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors Cancer 95 1879 1885 10.1002/cncr.10918 1:CAS:528:DC%2BD38XovFSqs70%3D 12404281 (Pubitemid 35222167)
23. B. Pauwels A.E. Korst F. Lardon, et al. 2005 Combined modality therapy of gemcitabine and radiation Oncologist 10 34 51 10.1634/theoncologist.10-1-34 1:CAS:528:DC%2BD2MXhs1CjsLY%3D 15632251 (Pubitemid 40171250)